Jun 18, 2019 (11.00 AM) 25 years of DNA Encoded Chemistry: managing serendipity in pre-clinical small molecule drug discovery?” Barry Morgan HitGen Inc., Chengdu, China & University of Texas Health Sciences, Institute for Molecular Medicine, Houston Texas
Events
16th Annual Meeting of the Bioinformatics Italian Society
June 26-28 Palermo, Italy 16th Annual Meeting of the Bioinformatics Italian Society
Glioma in 2019: Standard of care of IDHwt glioblastoma and IDHmt lower grade glioma Martin Van Den Bent
May 16, 2019 (2.00 PM) Glioma in 2019: Standard of care of IDHwt glioblastoma and IDHmt lower grade glioma Martin Van Den Bent Neuro-Oncology Unit at Erasmus MC Cancer Center, Rotterdam, Netherlands
International School of Process chemistry
May 12-15 Gargnano, Italy International School of Process chemistry
Terapie personalizzate nelle neoplasie mieloidi
April 11-12 Milan, Italy Terapie personalizzate nelle neoplasie mieloidi
15th Annual PEGS Boston
April 8-12 Boston, MA, USA 15th Annual PEGS Boston
Keystone symposium Proteomics and its Application to Translational and Precision Medicine
April 7–11 Stockholm, Sweden Keystone symposium Proteomics and its Application to Translational and Precision Medicine
257th ACS National Meeting & Exposition
March 31 - April 4 Orlando, Florida, USA 257th ACS National Meeting & Exposition
AACR 2019
March 29 - April 3 Atlanta, Georgia, USA AACR 2019
6th CDDD Meeting computationally driven drug discovery
March 28-29 Rome, Italy 6th CDDD Meeting computationally driven drug discovery
3rd World Conference on Cancer biology and immunology
March 11-12 Milan, Italy 3rd World Conference on Cancer biology and immunology
The physic of collective cancer migration
November 13, 2018 (1:30 PM) The physic of collective cancer migration Giorgio Scita Tumor Cell Migration Unit, IFOM Milano & Department of Oncology, University of Milan
Pre-clinical mouse models and breast cancer organoids reveal clues to therapeutic resistance and disease progression
November 20, 2018 (1:30 PM) Pre-clinical mouse models and breast cancer organoids reveal clues to therapeutic resistance and disease progression Kristina Havas Metabolism, Epigenetics and Breast Cancer, FIRC Institute for Molecular Oncology, IFOM Milan
Pathology Lab for Translational Medicine
October 10, 2018 (1:30 PM) Pathology Lab for Translational Medicine Giancarlo Pruneri Dip. Anatomia Patologica 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Treatment options in high risk multiple myeloma
October 16, 2018 (1:30 PM) Treatment options in high risk multiple myeloma Paolo Corradini Dip. Oncologia Medica ed Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Welcome and Check out our new motion picture!